News
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Adding this $4 vegetable to your diet may help you lose weight, prevent high blood sugar levels and brain inflammation, a ...
In an about-face, the administration is cracking down on so-called skin substitutes, overused treatments that cost Medicare ...
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results